Induction of feline immunodeficiency virus specific antibodies in cats with an attenuated Salmonella strain expressing the Gag protein.
Salmonella typhimurium aroA strains (SL3261), expressing high levels of the Gag protein of feline immunodeficiency virus (FIV) fused with maltose binding protein (SL3261-MFG), were constructed using an invertible promoter system that allows the stable expression of heterologous antigens at levels toxic for bacteria. A SL3261 strain expressing the B subunit of cholera toxin by a similar system (SL3261-CtxB) served as a control in FIV-immunization experiments. Cats immunized once orally or intraperitoneally with SL3261-MFG or SL3261-CtxB all developed serum antibodies to SL3261 lipopolysaccharide and against maltose binding protein or the B subunit of cholera toxin, respectively. Two intraperitoneal immunizations with SL3261-MFG also resulted in the development of Gag specific serum antibodies. Two oral immunizations with SL3261-MFG primed for a Gag specific response, which was demonstrated upon FIV challenge. All challenged cats became infe
|Keywords||*Genetic Vectors, *Salmonella typhimurium, 0 (Antibodies, Viral), 0 (Gene Products, gag), 0 (Genetic Vectors), 0 (Plasmids), 0 (Vaccines, Attenuated), 0 (Vaccines, Synthetic), 0 (Viral Vaccines), Animals, Antibodies, Viral/biosynthesis/*immunology, Cats, Gene Expression, Gene Products, gag/genetics/*immunology, Immunodeficiency Virus, Feline/*immunology, Inversion (Genetics), Plasmids, Support, Non-U.S. Gov't, Vaccines, Attenuated/immunology, Vaccines, Synthetic/immunology, Viral Vaccines/*immunology|